SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRAV.L Regulatory News (RAV)

  • There is currently no data for RAV

Rule 8.3- Raven Mount plc

22 Apr 2009 10:37

RNS Number : 9728Q
Silchester International Inv.Ld
22 April 2009
 

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

SILCHESTER INTERNATIONAL INVESTORS LTD

Company dealt in

RAVEN MOUNT PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORDINARY

Date of dealing

21st April 2009

 

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities 

7,475,841

6.88

(2) Derivatives (other than options)

N/A

(3) Options and agreements to purchase/sell

N/A

Total

7,475,841

6.88

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 

Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales

 

Purchase/sale 

Number of securities

Price per unit (Note 5)

SALE

25,000

46.0 GBp

 

(b) Derivatives transactions (other than options)

 

Product name,

e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

N/A

N/A

N/A

N/A

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product

name, e.g.

call option 

Writing,

selling,

purchasing,

varying etc.

Number of

securities to

which the

option

relates

(Note 7)

Exercise

price 

Type, e.g.

American,

European

etc.

Expiry

date

Option

money

paid/received

per unit (Note

5) 

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

 

(ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

N/A

N/A

N/A

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)

NO

 

Date of disclosure

23rd April 2009

Contact name

Alison Ravenscroft

Telephone number

020 7518 7124

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETIIFVASEIFFIA
Date   Source Headline
26th May 202212:00 pmRNSResult of General Meeting
12th May 20223:01 pmRNSPreference Share Dividend (RAVP)
6th May 20222:53 pmRNSPublication of Circulars
28th Apr 20224:00 pmRNSNotice of Delay to Publication of Annual Accounts
30th Mar 20227:00 amRNSPreference Share Dividend (RAVP)
17th Mar 20227:47 amRNSProposed De-listing
17th Mar 20227:43 amRNSSuspension of Shares
15th Mar 20224:41 pmRNSSecond Price Monitoring Extn
15th Mar 20224:35 pmRNSPrice Monitoring Extension
2nd Mar 20229:03 amRNSCompany Update
24th Feb 20227:00 amRNSScrip Dividend Circular (RAVP)
10th Feb 20227:00 amRNSPreference Share Dividend (RAVP)
28th Jan 20224:41 pmRNSSecond Price Monitoring Extn
28th Jan 20224:36 pmRNSPrice Monitoring Extension
24th Jan 20224:41 pmRNSSecond Price Monitoring Extn
24th Jan 20224:37 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSTotal Voting Rights
31st Dec 202112:29 pmRNSDirector/PDMR Shareholding
30th Dec 20217:00 amRNSIssue of New Preference Shares (RAVP)
20th Dec 20214:40 pmRNSSecond Price Monitoring Extn
20th Dec 20214:35 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSUpdate re: AGM
2nd Dec 20213:45 pmRNSDirectorate Change
25th Nov 20217:00 amRNSScrip Dividend Circular (RAVP)
11th Nov 20217:00 amRNSPreference Share Dividend (RAVP)
2nd Nov 20213:00 pmRNSDirector/PDMR Shareholding
12th Oct 20214:15 pmRNSAppointment of Joint Corporate Broker
1st Oct 20217:00 amRNSTotal Voting Rights
29th Sep 20217:00 amRNSIssue of preference shares (RAVP)
10th Sep 20217:00 amEQSRaven Property Group (RAV): Increasing rents and property valuations
31st Aug 20217:00 amRNSHalf-year Report
26th Aug 20217:00 amRNSScrip Dividend Circular (RAVP)
12th Aug 20217:00 amRNSPreference Share Dividend (RAVP)
1st Jul 20214:00 pmRNSDirector/PDMR Shareholding
1st Jul 20217:00 amRNSTotal Voting Rights
29th Jun 20217:00 amRNSIssue of preference shares (RAVP)
21st Jun 20217:00 amRNSTotal Voting Rights
18th Jun 20214:35 pmRNSPrice Monitoring Extension
18th Jun 20214:00 pmRNSResult of AGM
10th Jun 20218:00 amRNSUpdate on Tender Offer
8th Jun 20214:35 pmRNSPrice Monitoring Extension
1st Jun 20217:00 amRNSTotal Voting Rights
27th May 20217:00 amRNSScrip Dividend Circular (RAVP)
26th May 20214:41 pmRNSSecond Price Monitoring Extn
26th May 20214:36 pmRNSPrice Monitoring Extension
25th May 20213:00 pmRNSDirector/PDMR Shareholding
19th May 20213:30 pmRNSTender Offer and Notice of AGM
13th May 20217:00 amRNSPreference Share Dividend (RAVP)
11th May 202111:25 amRNSHolding(s) in Company
11th May 202111:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.